Delia Rota Scalabrini
0000-0003-0744-6390
FPO-IRCSS Candiolo
4 papers found
Refreshing results…
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
Missing publications? Search for publications with a matching author name.